Skip to main content

Advertisement

SpringerLink
Log in

Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Antiphospholipid (aPL) antibodies are often detected in systemic autoimmune diseases. The aim of the study was to examine the correlation between the presence of aPL and certain markers of renal function in systemic sclerosis (SSc). Fifty patients (pts) with SSc were examined for the presence of antibodies to cardiolipin (aCL) and to anti-beta 2 glycoprotein I (a-B2GPI) in immunoglobulin M (IgM) and IgG class. Moreover, serum levels of creatinine, cystatin C, and glomerular filtration rate (GFR) were determined in all patients. In all studied pts together, three multiple-regression analyses were performed with one set cystatin C as a dependent variable, in the second GFR according to the Cockcroft–Gault formula and in the third creatinine clearance by Modification of Diet in Renal Disease (MDRD) formula. As independent variables, aPL of either type were inserted in addition to disease duration and age. IgG aCL was significantly positively associated with serum cystatin C (p = 0.002), significantly negatively associated with creatinine clearance according to the Cockcroft–Gault and MDRD formula (p = 0.01 and 0.02, respectively). IgG a-B2GPI was significantly negatively associated with creatinine clearance according to the Cockcroft–Gault (p = 0.03) and MDRD (p = 0.01) formula. IgM aCL and IgM a-B2GPI were not associated with any markers of the renal function. Our study suggests the relationship between kidney involvement and the positivity for some aPL in patients with SSc. Positivity for IgG aCL and IgG a-B2GPI in patients with SSc without secondary antiphospholipid syndrome seems to be connected with decrease of glomerular filtration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gupta R, Bammigatti C, Dinda AK, Marwaha V, Gupta S (2007) Prevalence of renal involvement in Indian patients with systemic sclerosis. Indian J Med Sci 61:91–96

    Article  PubMed  CAS  Google Scholar 

  2. Guerini S, Cavazzana I, Venturelli C, Rozzi M, Turina S, Sottini L, Tardanico R, Franceschini F, Scolari F (2007) Kidney in systemic sclerosis. G Ital Nefrol 24:295–310

    PubMed  CAS  Google Scholar 

  3. Wielosz E, Majdan M, Suszek D, Smarz-Widelska I, Korolczuk A, Korobowicz E (2007) Nephrotic syndrome as clinical manifestation of systemic sclerosis. Rheumatol Int 27:1087–1089

    Article  PubMed  Google Scholar 

  4. Helfrich DJ, Banner B, Steen VD, Medsger TA (1989) Normotensive renal failure in systemic sclerosis. Arthritis Rheum 32:1128–1134

    Article  PubMed  CAS  Google Scholar 

  5. Steen VD (1994) Renal involvement in systemic sclerosis. Clin Dermatol 12:253–258

    Article  PubMed  CAS  Google Scholar 

  6. Steen VD, Syzd A, Johnson JP, Greenberg A, Medsger TA (2005) Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 32:649–655

    PubMed  Google Scholar 

  7. Distler JH, Kalden JR, Gray S, Distler O (2004) Vascular changes in the pathogenesis of systemic sclerosis. Z Rheumatol 63:446–450

    Article  PubMed  CAS  Google Scholar 

  8. Abraham D, Distler O (2007) How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther 9:2

    Article  CAS  Google Scholar 

  9. Assous N, Allanore Y, Batteux F, Meune C, Toulon P, Weill B, Kahan A (2005) Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin Exp Rheumatol 23:199–204

    PubMed  CAS  Google Scholar 

  10. Ihn H, Sato S, Fujimoto K, Kikuchi K, Igarashi A, Soma Y, Tamaki K, Takehara K (1996) Measurement of anticardiolipin antibodies by ELISA using B2-glycoprotein I (B2-GPI) in systemic sclerosis. Clin Exp Immunol 105:475–479

    Article  PubMed  CAS  Google Scholar 

  11. Lima J, Fonollosa V, Fernandez-Cortijo J, Ordi J, Cuenca R, Khamashta MA, Vilardell M, Simeon PK, Pico M (1991) Platelet activation, endothelial cell dysfunction in absence of anticardiolipin antibodies in systemic sclerosis. J Rheumatol 18:1833–1836

    PubMed  CAS  Google Scholar 

  12. LeRoy EC, Black C, Fleishmajer R (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–204

    PubMed  CAS  Google Scholar 

  13. Cockroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41

    Article  Google Scholar 

  14. National-Kidney-Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39:S1–S266

    Article  Google Scholar 

  15. Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5:80–93

    PubMed  CAS  Google Scholar 

  16. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galaeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quere I, Hachulla E, Vasconcelos C, Roch B, Fernandez–Nebro A, Boffa MC, Hughes GR, Ingelmo M (2002) Antiphospholipid syndrome. Clinical and immunologic manifestations and pattern of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019–1027

    Article  PubMed  Google Scholar 

  17. Picillo U, Migliaresi S, Marcialis MR, Feruzzi AM, Tirri G (1995) Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis. Autoimmunity 20:1–7

    Article  PubMed  CAS  Google Scholar 

  18. Pope JE, Thompson A (2000) The frequency and significance of anticardiolipin antibodies in scleroderma. J Rheumatol 27:1450–1452

    PubMed  CAS  Google Scholar 

  19. Wielosz E, Majdan M, Zychowska I, Jeleniewicz R (2008) Coexistence of five autoimmune diseases: diagnostic and therapeutic difficulties. Rheumatol Int 28:913–923

    Article  Google Scholar 

  20. Malia RG, Greaves M, Rowlands LM, Lawrence AC, Hume A, Rowell NR, Moult J, Holt CM, Lindsey N, Hughes P (1988) Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations. Clin Exp Immunol 73:456–460

    PubMed  CAS  Google Scholar 

  21. Steen VD, Medsger TA (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis and Rheum 41:1613–1619

    Article  CAS  Google Scholar 

  22. Sulik A, Kowal-Bielecka O, Domysławska I, Chwiećko J, Sierakowski S (2005) The prevalence and clinical significance of antiphospholipid antibodies in the patients with systemic sclerosis-preliminary report. Rocz Akad Med Bialymst 50:228–231

    PubMed  Google Scholar 

  23. Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid Syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies. Arthritis Rheum 50:2569–2579

    Article  PubMed  Google Scholar 

  24. Tektonidou MG (2008) Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clin RevAllerg 36:131–140. doi:10.1007/s1216-008-8112-z

    Google Scholar 

  25. Uthman I, Khamashta M (2006) Antiphospholipid syndrome and the kidneys. Semin Arthritis Rheum 35:360–367

    Article  PubMed  CAS  Google Scholar 

  26. Wieczorowska –Tobis K, Niemir ZI, Guzik P, Breborowicz D, Oreopoulos DG (2006) Difference in estimated GFR with two different formulas in elderly individuals. Int Urol Nephrol 38:381–385

    Article  PubMed  Google Scholar 

  27. Sato S, Fujimoto M, Hasegawa M, Takehara K (2003) Antiphospholipid antibody in localized scleroderma. Ann Rheum Dis 62:771–774

    Article  PubMed  CAS  Google Scholar 

  28. Ichikawa H, Amano T, Fukuda S, Kataoka H, Kawabata K, Nagake Y, Makino H (1998) A case of scleroderma renal crisis with massive pericardial effusion and positivity on antiphospholipid antibody test. Nippon Jinzo Gakkai Shi 40:295–300

    PubMed  CAS  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

  1. Department of Rheumatology and Connective Tissue Diseases, Medical University of Lublin, Jaczewskiego 8 street, 20-090, Lublin, Poland

    Ewa Wielosz, Magdalena Dryglewska & Maria Majdan

Authors
  1. Ewa Wielosz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magdalena Dryglewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Majdan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ewa Wielosz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wielosz, E., Dryglewska, M. & Majdan, M. Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis. Clin Rheumatol 28, 955–959 (2009). https://doi.org/10.1007/s10067-009-1188-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-009-1188-x

Keywords

Search

Navigation